US Patent Issued to REMEGEN on March 17 for "Anti-Claudin 18.2 antibody and antibody-drug conjugate thereof" (Chinese Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,577,320, issued on March 17, was assigned to REMEGEN Co. LTD. (Yantai, China).

"Anti-Claudin 18.2 antibody and antibody-drug conjugate thereof" was invented by Jianmin Fang (Yantai, China), Yuanhao Li (Yantai, China), Marie M. Zhu (Yantai, China), Jing Jiang (Yantai, China), Yuelei Shen (Yantai, China), Shenjun Li (Yantai, China), Wenting Luo (Yantai, China), Xiaoping Zhang (Yantai, China), Lili Wang (Yantai, China), Ling Wang (Yantai, China), Qinbin Zhang (Yantai, China) and Fang Yang (Yantai, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are an antibody targeting Claudin 18.2, an antibody-drug conjugate, and use thereof in treatment o...